Millennium Pharmacon International (SDPC) — Long-term Investment Intensity
Millennium Pharmacon International (SDPC) has a Long-term Investment Intensity of 4.3% as of September 2019. Long-term investments of Rp54.00 Billion represent 4.3% of total assets of Rp1.26 Trillion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See SDPC book value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Millennium Pharmacon International Long-term Investment Intensity (2017–2018)
This chart shows how Millennium Pharmacon International's Long-term Investment Intensity has evolved across 2 annual periods from 2017 to 2018. As of September 2019, the intensity stands at 4.3%, reflecting long-term investments of Rp54.00 Billion against total assets of Rp1.26 Trillion IDR. Also explore how large is Millennium Pharmacon International's balance sheet for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Millennium Pharmacon International (2017–2018)
The table below presents the year-by-year Long-term Investment Intensity for Millennium Pharmacon International from 2017 to 2018, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Millennium Pharmacon International market cap and net worth.
| Year | LT Investment Intensity | LT Investments (IDR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.5% | Rp54.00 Billion | Rp1.19 Trillion | ▼ -1.2 pp |
| 2017 | 5.8% | Rp54.00 Billion | Rp938.01 Billion | — |